USPTO serial 79330764
EPIDIOLEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 14, 2023
- Examiner
- MEYERS, MORGAN LAURA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EPIDIOLEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael T. Olsen
Michael T. Olsen Winthrop & Weinstine, P.A.225 South 6th Street, Suite 3500Minneapolis, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 041 | Educational services namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; instruction and training services, in the field of pharmaceutical product development of medicines and cancer treatments; education services relating to medicine, namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; organising and conducting seminars and conventions in the field of medicine; information, advisory and consultancy services in relation to all of the aforesaid services | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis, testing in the field of medicines, healthcare, and cancer treatment, and research and design relating thereto; chemical analysis; chemical research; research and development of new products for others; research and development on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; conducting clinical trials in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; information, advisory and consultancy services in relation to all of the aforesaid services | ACTIVE | — |
| 044 | Medical services, veterinary services, medical analysis services; pharmaceutical services; pharmaceutical advisory services; provision of pharmaceutical information; providing information in the field of medicine; horticultural services; information, advisory and consultancy services in relation to all of the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Jazz Pharmaceuticals Research UK Limited
- Other trademarks owned by GW Research Ltd
- Other trademarks owned by GW Research Ltd
- Other trademarks owned by GW Research Ltd
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EPIDIOLEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 11, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 13, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 18, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 17, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 14, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 14, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 14, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 12, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 29, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 29, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 23, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 23, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 9, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 26, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 13, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 12, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 12, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 25, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 29, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 29, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 1, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 18, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 17, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 1, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 27, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 20, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jan 6, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |